Sign in

CIK 0001528115 · Non-accelerated filer<br>Smaller reporting company

Annexon, Inc.

Sign in to watch
Ticker
ANNX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
275414423
Phone
(650) 822-5500
Business address
1400 SIERRA POINT PARKWAY, BLDG C, SUITE 200, BRISBANE, CA, 94005
  1. 4 Open-market sale EVP & CHIEF SCIENTIFIC OFFICER sold 5,290 shares at $5.10 ($26,979)
  2. 4 Open-market sale EVP & CHIEF INNOVATION OFFICER sold 7,857 shares at $5.11 ($40,149)
  3. 4 Open-market sale EVP & CHIEF BUSINESS OFFICER sold 6,225 shares at $5.10 ($31,748)
  4. 144 Insider Sale of Securities
  5. 144 Insider Sale of Securities
  6. 144 Insider Sale of Securities
  7. 144 Insider Sale of Securities
  8. 144 Insider Sale of Securities
  9. 8-K Event Executive or director change
  10. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  11. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  12. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  13. 8-K Event Regulation FD disclosure
  14. 8-K Event Other events
  15. 4 Open-market buy Director bought 4,115 shares at $5.02 ($20,657)
  16. 4 Open-market buy Director bought 33,000 shares at $4.19 ($138,270)
  17. 4 Open-market buy Director bought 4,115 shares at $4.47 ($18,394)
  18. 4 Open-market buy Director bought 822,613 shares at an average $4.38 ($3,600,784)
  19. SCHEDULE 13D/A Stake Beneficial Ownership Report
  20. 4 Open-market buy Director bought 1,500,000 shares at an average $3.37 ($5,055,000)

Page 4 of 27 · 524 filings